The Biotechnology team at Innovate UK KTN focuses on Industrial Biotechnology (IB), Engineering Biology (EB, commonly referred to as Synthetic Biology) and Microbiomes.
These technologies have the potential to carry out transformations which would not be feasible, technically or economically, using traditional chemistry. They hold the potential to make entirely new materials or to develop processes which run at low or ambient temperatures, thus reducing energy consumption. Consequently they can have a major impact in the UK’s move to Net Zero emissions.
The team works with all sectors that either use, or are interested in using, biotechnology in their business, in particular Chemicals, Pharmaceuticals, Home & Personal Care, AgroChemicals, Food and Drink – and many more.
Our experts use deep knowledge of the sector to help you and your business innovate through access to funding, expertise and building connections and collaborations. The team works closely with national bodies such as the Industrial Biotechnology Leadership Forum (IBLF) and the Engineering Biology Leadership Council (EBLC).
Follow us on Twitter: @KTN_Biotech
Our current focus in this area
Engineering Biology (EngBio) provides us with the opportunity to step away from traditional methods and provide innovative solutions for challenges brought by climate change and the associated impact areas, like food availability and the need for sustainable feedstocks.
Similar to Engineering Biology, Industrial Biotech impacts numerous sectors including Chemistry, Materials, Healthcare and AgriFood. It also has a significant role in the development of a Circular Economy by using waste as a feedstock for biobased products.
The Microbiome Innovation Network (formerly SIG) aims to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia.
SBRI: Vaccine development for potential epidemic diseases stage 1
Opens: 31/05/2023 Closes: 12/07/2023
Organisations can apply for a share of up to £25m to develop vaccine candidates, technologies and platforms, up to and including phase 1 clinical trials.
Engineering Biology Collaborative R&D Round 2
Opens: 30/05/2023 Closes: 26/07/2023
UK businesses can apply for a share of up to £6.7m to develop Engineering Biology technologies, processes, products, services, or solutions to societal challenges.
Advancing precision medicine: Round 2
Opens: 15/05/2023 Closes: 28/06/2023
Up to £20m to develop digital and data-enabled tools and multi-modal approaches for oncology, musculoskeletal/cardiovascular and chronic conditions.
Related Events and Recordings
UK Phage Innovation Showcase
09.30 - 16.30 | Leicester/online
Industrial Applications of Biomass: The Biorefinery Concept – creating high value product streams from biomass
10.00 - 12.00 | Online
Innovate UK KTN Phage Innovation Network - Online launch event
10.00 - 11.30 | Online
Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK
We are pleased to announce our pilot accelerators, in collaboration with the Medical Research Council (MRC), which will allow spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from the innovation ecosystem.
Innovate UK KTN Launches Phage Innovation Network
Innovate UK KTN’s Phage Innovation Network will be instrumental in driving innovation in the regulation and development of PBTs for applications across multiple sectors.